PDL BioPharma, Inc. (PDLI) Tops Q4 EPS 2c
Tweet Send to a Friend
PDL BioPharma, Inc. (NASDAQ: PDLI) reported Q4 EPS of $34.00 ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
